Addictionology Center is directed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, a physician board certified in addiction medicine and, separately, in pain medicine and interventional pain. Addiction treatment is a field where credentials are frequently implied and rarely stated, so they are stated here, along with the public records to check them against.
Why an addiction practice is run by a pain physician
Most people treated here did not set out to find a drug. A large share of opioid dependence began as a legitimate attempt to treat real pain, prescribed by someone acting in good faith.
That history creates a trap most addiction programs are not built to escape. A clinician who can only treat the dependence has to ask the patient to accept the pain that started it. A clinician who can only treat the pain tends to reach for the prescription that caused the problem. Each is doing half the job, and the half left undone is usually what brings the patient back.
Treating both at once is what makes it possible to reduce or stop opioids while the pain that produced them is addressed by other means. Lowering the clinical need for a medication is a different event from a taper imposed on its own, and patients experience it differently. It is the reason drug addiction treatment and alcohol addiction treatment here are run alongside pain care rather than in a separate building, and the reason poorly managed chronic pain keeps turning up inside opioid use disorder.
Published opioid outcomes
In August 2026, on International Overdose Awareness Day, Dr. Padda published the opioid data from his interventional pain practice rather than a position statement. Patients arrive on an average of more than 90 morphine milligram equivalents a day after more than two and a half years in pain. Within 90 days of active interventional treatment, 21% are completely off opioid pain medication; within one year, 34% are. Of those who cannot be fully weaned, the large majority are brought below 30 MME a day.
The relevance here is the mechanism rather than the percentages: treating the structure producing the pain lowers the clinical need for the medication. Those are practice-reported figures from his own patient population, not trial outcomes, and individual results vary. Reported by AP News; the full release is here.
Care is delivered in person
Prescribing decisions are made in the office, face to face. Induction and maintenance with buprenorphine and naloxone are managed the same way, by a physician who is also examining the pain problem underneath. Patients are seen at the Woodson Road office and from across Missouri and Illinois.
Board certification
Dr. Padda holds five American board certifications:
- Addiction Medicine — American Board of Addiction Medicine
- Interventional Pain — American Board of Interventional Pain Physicians (ABIPP)
- Pain Medicine — American Board of Pain Medicine
- Anesthesiology — American Board of Anesthesiology
- Obesity Medicine — American Board of Obesity Medicine
He is also a Fellow of Interventional Pain Physicians (FIPP), a Diplomate of the Society of Metabolic Health Practitioners, a Certified Physician Executive (CPE), and a certified rater for the Montreal Cognitive Assessment.
Training and appointments relevant to this work
Dr. Padda took his MD at the University of Missouri–Kansas City, trained in general surgery at Cook County Hospital, and completed anesthesiology residencies at Illinois Masonic Medical Center and at Washington University / Barnes Hospital, where he was Chief Resident in 1991–92. He holds an MBA from Saint Louis University.
Since 2024 he has been faculty in the Kansas City University and Freeman Health System psychiatry residency, teaching pain and addiction. He is President of the Missouri Society of Interventional Pain Physicians, a Board Member and Examiner for the American Board of Interventional Pain Physicians, and a past member of the Board of Directors of the American Society of Interventional Pain Physicians. He has twice delivered the keynote at the ASIPP national meeting, and his work is published in Neuromodulation, Pain Medicine, Critical Care Medicine, Anesthesia & Analgesia and Pain Physician.
His earlier academic career, publications and the full record are set out on his Padda Institute physician page.
Credential verification
None of this has to be taken on trust. Dr. Padda is licensed in Missouri and Illinois, and the record is public.
- National Provider Identifier: 1427035955
- Missouri medical license: MD 100572
- Healthgrades profile
- Doximity profile
Where else he practices
This is one of several practices directed by Dr. Padda. For chronic and interventional pain generally, the affiliated practice is the Padda Institute in St. Louis. He holds full staff privileges at Anderson Hospital in Maryville, Illinois, and privileges at SSM Health St. Clare Hospital in Fenton, Missouri. He is also Chief Medical Officer of Valor Villages, the St. Louis 501(c)(3) nonprofit that houses veterans and children in crisis.
Starting treatment
New patients can enroll now or contact the office to arrange a first visit.
Board certifications and professional affiliations
Dr. Gurpreet Singh Padda, MD, MBA, MHP holds five board certifications and maintains the professional affiliations below.
